Physiological disposition of verapamil in man. 1976

M Schomerus, and B Spiegelhalder, and B Stieren, and M Eichelbaum

14C-D,L-verapamil was administered intravenously (10 mg) and orally (80 mg) to five volunteer patients. Plasma concentrations of verapamil, which were determined by mass fragmentography, declined bi-exponentially with half-lives of the chi-phase ranging from 18 to 35 min and of the beta-phase from 170 to 440 min. The apparent volume of distribution ranged from 270 to 460 litre and plasma clearance from 730 to 1980 ml/min. Following oral administration absorption was almost complete as judged from the area under the curve (AUC) of 14C-activity and cumulative urinary excretion of 14C. After intravenous infusion of verapamil about 80% of the radioactivity administered could be recovered in urine and faeces within 5 d. Despite its almost complete absorption after oral administration verapamil was shown to undergo extensive first pass metabolism as the bioavailability was only 10 to 22%. Rapid biotransformation had occurred as only a small percentage of AUC of 14C was seen to correspond to unchanged verapamil after both intravenous and oral administration.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

M Schomerus, and B Spiegelhalder, and B Stieren, and M Eichelbaum
January 1946, Federation proceedings,
M Schomerus, and B Spiegelhalder, and B Stieren, and M Eichelbaum
August 1950, The Journal of pharmacology and experimental therapeutics,
M Schomerus, and B Spiegelhalder, and B Stieren, and M Eichelbaum
December 1975, European journal of clinical pharmacology,
M Schomerus, and B Spiegelhalder, and B Stieren, and M Eichelbaum
March 1948, Federation proceedings,
M Schomerus, and B Spiegelhalder, and B Stieren, and M Eichelbaum
March 1948, Federation proceedings,
M Schomerus, and B Spiegelhalder, and B Stieren, and M Eichelbaum
January 1974, Naunyn-Schmiedeberg's archives of pharmacology,
M Schomerus, and B Spiegelhalder, and B Stieren, and M Eichelbaum
April 1960, The Journal of pharmacology and experimental therapeutics,
M Schomerus, and B Spiegelhalder, and B Stieren, and M Eichelbaum
December 1955, The Journal of clinical investigation,
M Schomerus, and B Spiegelhalder, and B Stieren, and M Eichelbaum
January 1989, Drug metabolism and disposition: the biological fate of chemicals,
M Schomerus, and B Spiegelhalder, and B Stieren, and M Eichelbaum
January 1946, Federation proceedings,
Copied contents to your clipboard!